Psychedelic Psilocybin Could Cut Cravings in Alcoholics
1.2 min readPublished On: November 18th, 2021By News Team
NEW YORK–Alcohol is a scourge on humanity. Alcohol accounts for about 3 million deaths worldwide annually, and there are few approved drugs to treat alcohol use disorder.
Along comes Psilocybin, the active ingredient in magic mushrooms, has drawn interest as a potential remedy for the disorder in Germany. Their findings were reported in the journal Science Advances.
Psilocybin being tested in several diseases, including depression. Compass Pathways reported earlier this month that its psilocybin improved symptoms in people with treatment-resistant depression in their phase IIb trial.
More recently, researchers at the University of Heidelberg treated rat models of alcohol addiction with psilocybin and found that the psychedelic reduced cravings.
The promising effects of psilocybin stem from the compound’s ability to restore expression of a specific glutamate receptor known as mGluR. That brain receptor causes both alcohol cravings and impairments in “executive functions,” such as self-control and decision-making, as demonstrated in the study.
The researchers mimic’d the depdency and addiction process in humans in rats. Researchers gave rats one of two different doses of psilocybin to reduce relapses so common to the disease of alcoholism. Both doses were effective compared to a control treatment the researchers said. They also found that lower levels of mGluR2 in certain regions of the cortex trigger alcohol-seeking behavior and impaired cognitive flexibility in the animal model.
The Heidelberg team’s research comes amid a wave of investor interest in psychedelics as treatments for depression, addiction and other conditions.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
SALT LAKE CITY – (NORML)– The legalization of cananbis is associated with improvements in police clearance rates for multiple types of violent crimes, according to data published online ahead of print in The International Journal of Drug ...
LOS ANGELES- C3 Industries , a multi-state, vertically integrated cannabis company with headquarters in Ann Arbor, MI, has announced the launch of its new 15,000 square foot manufacturing facility in St. Louis, Missouri, which is expected to ...
WASHINGTON, D.C.– The US federal government has granted researchers studying the therapeutic potential of psychedelic medicine for the first time in 50 years. Indeed, the NIH was a major funder of the early research that ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more